Thyroid eye disease

BMJ (Online)

Volumn 338, Issue 7695, 2009, Pages 645-650

  Perros, Petros ^a   Neoh, Christopher ^a   Dickinson, Jane ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AZATHIOPRINE; LUBRICATING AGENT; METHYLPREDNISOLONE; RADIOACTIVE IODINE; RITUXIMAB; STEROID; THYROID ANTIBODY;

ALLERGIC CONJUNCTIVITIS; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; HUMAN; INCIDENCE; IRRADIATION; MYASTHENIA GRAVIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; ORBIT TUMOR; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; THYROIDECTOMY; THYROTOXICOSIS; UNSPECIFIED SIDE EFFECT; WEGENER GRANULOMATOSIS;

GRAVES OPHTHALMOPATHY; HUMANS; REFERRAL AND CONSULTATION; THYROTOXICOSIS;

EID: 62949098032     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b560     Document Type: Review

References (22)

1. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen S|, llstrup DM, GarrityJA, et al.The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 1995;120:511-7.
2. Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, Kahaly GJ, et al. Questionnaire survey on the managernent of Graves'orbitopathy in Europe. Eur J Endocrinol 2006;155:207-11.
3. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008;158:273-85.
4. Salvi M, Zhang ZG, Haegert D, Woo M, Liberman A, Cadarso L, et al. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 1990;70:89-94.
5. Khoo TK, Bahn RS. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 2007;17:1013-8.
6. Orgiazzi J. Pathogenesis. In: Wiersinga WM, Kahaly GJ, eds. Graves' orbitopathy. A multidisciplinary approach. Basel: Karger, 2008:41- 56.
7. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2003;24:802-35.
8. Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 2008;18:953-8.
9. Boboridis K, Perros P. General management plan. In: Wiersinga WM, Kahaly GJ, eds. Graves' orbitopathy. A multidisciplinary approach. Basel: Karger, 2008:88-95.
10. Wiersinga WM. Management of Graves' ophthalmopathy. Nat Clin Pract Endocrinol Metab 2007;3:396-404.
11. Kendall-Taylor P. Natural history. In: Wiersinga WM, Kahaly GJ, eds. Graves' orbitopathy. A multidisciplinary approach. Basel: Karger, 2008:78-87.
12. Wiersinga WM, Perros P, Kahaly GJ, Mounts MP, Baldeschi L, Boboridis K, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves'Orbitopathy recommendationsto genera lists, specialists and clinical researchers. Eur J Endocrinol 2006;155:387-9.
13. Bartalena L, Tanda ML, Piantanida E, Lai A. Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. Eur J Endocrinol 2005;153:13-4.
14. Perros P, Kendall-TaylorP, Neoh C, FrewinS, Dickinson J. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 2005;90:5321-3.
15. Hart RH, Perros P. Glucocorticoids in the medical management of Graves' ophthalmopathy. Minerva Endocrinol 2003;28:223-31.
16. Hart RH, Kendall-Taylor P, Crombie A, Perros P. Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome. J Ocul Pharmacol Ther 2005;21:328-36.
17. Mounts MP. Does radiotherapy have a role in the management of thyroid orbitopathy? View 2. Br J Ophthalmol 2002;86:104-6.
18. Neoh C, Eckstein A. Eyelid surgery. In: Wiersinga WM, Kahaly GJ, eds. Graves' orbitopathy. A multidisciplinary approach. Basel: Karger, 2008:188-200.
19. Baldeschi L. Rehabilitative surgery. In: Wiersinga WM, Kahaly GJ, eds. Graves' orbitopathy. A multidisciplinary approach. Basel: Karger, 2008:160-175.
20. Dickinson AJ, Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (0xf) 2001;55:283-303.
21. Coulterl, Frewin S, KrassasGE, Perros P. Psychological implications of Graves' orbitopathy. Eur J Endocrinol 2007;157:127-31.
22. Krassas GE, Perros P. Prevention of thyroid associated- ophthalmopathy in children and adults: current views and management of preventable risk factors. Pediatr Endocrinol Rev 2007;4:218-24.